Overdose Trends Among Women
Overdose deaths among women have risen sharply in recent years, driven largely by synthetic opioids such as fentanyl. The CDC reports that female overdose mortality rates increased by over 60% between 2019 and 2022, with the sharpest gains in ages 25 to 44. The latest provisional data show that overdose is now a leading cause of injury death for women in the United States, surpassing motor vehicle crashes in multiple states. CDC drug overdose data tracks these trends by age, sex, and substance type.
Emergency department visits for overdose among women also climbed, with benzodiazepines and stimulants frequently involved alongside opioids. Rural and non-Hispanic Black women experienced some of the fastest rate increases, according to federal surveillance. The overdose crisis now affects women across nearly every demographic, with disparities linked to access to treatment, prescribing patterns, and exposure to illicit fentanyl. National Institutes of Health analysis details demographic breakdowns of these emergency visits.
Financial and Economic Impact
The economic burden of overdose on women includes direct medical costs, lost labor productivity, and child welfare expenses. A 2023 study published in the journal Drug and Alcohol Dependence estimated the annual economic cost of opioid overdose in the United States at over one trillion dollars, with a growing share attributed to women of working age. Lost earnings from overdose deaths reduce household income and increase reliance on public programs, amplifying fiscal strain on families and local governments.
Healthcare and Insurance Costs
Hospitalizations for overdose among women generate significant charges, with average inpatient stays costing tens of thousands of dollars per event. Private insurers, Medicaid, and Medicare absorb a large share of these costs, while uninsured women often face substantial bills. The rise in fentanyl-related overdoses has increased demand for intensive care, raising per-case spending compared to earlier opioid waves. Forbes business council analysis outlines how employers and insurers are responding to these trends.
Response and Prevention Strategies
Federal and state agencies have expanded harm reduction programs, including naloxone distribution, syringe services, and medication for opioid use disorder. The Substance Abuse and Mental Health Services Administration funds grants targeting women-specific treatment, emphasizing prenatal and postpartum care. Overdose prevention sites and fentanyl test strip programs aim to reduce deaths, though legal and regulatory barriers vary by jurisdiction. SAMHSA treatment resources provide current guidance on evidence-based medications.
Workplace and Policy Interventions
Some large employers have introduced overdose prevention training and expanded employee assistance benefits, recognizing the impact on workforce stability. State legislatures have passed Good Samaritan laws and expanded naloxone access for community settings, including pharmacies. The SEC and other regulators have also flagged the financial risks that substance use disorders pose to public companies, particularly in industries with high injury and fatigue exposure. SEC corporate finance guidance notes disclosure considerations related to workforce health risks.